Manufacturing Of Covishield
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Serum Institute Halts Vaccine Production Over Millions Of Unused Doses
Serum Institute of India Ltd., the world's largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making fresh batches of shots after its stockpile grew to 200 million doses amid a global supply
-
Central Drug Regulator Approves Shelf Life Of COVID-19 Vaccines CoviShield, Covaxin, ZyCoV-D
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.
-
Omicron-Specific Booster Shot Possible, Says Adar Poonawalla To NDTV: Highlights
As new Covid strain 'Omicron' raises alarm across the globe, Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, in an exclusive interview to NDTV said that Omicron-specific booster shots are possibl
-
"Vaccine Hesitancy Greatest Threat" In Overcoming Covid: Adar Poonawalla
Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, today said vaccine hesitancy was the "greatest threat" in overcoming the pandemic.
-
"Stress And Anxiety": Adar Poonawalla On Initial Days Of Vaccine Drive
Adar Poonawalla, chief of the Serum Institute of India which manufactures the Covishield vaccine, today admitted to stress and anxiety in the initial days of the vaccination drive. The second wave, he added, was worse.
-
Covid Booster Shot "Early Next Year, But...": Adar Poonawalla to NDTV
Adar Poonawalla, the chief of Serum Institute which is manufacturing Covishield, today said the billionth dose of coronavirus vaccine is a milestone for India and over the next two months, the country will catch up further. There is even a possibili
-
"I Got India's Covishield Vaccine": UN General Assembly President Abdulla Shahid
President of the 76th session of the UN General Assembly Abdulla Shahid has said he had received the two doses of the Covishield vaccine manufactured in India, as have a "large portion" of other countries around the world.
-
"Look Forward To Welcome Indian Students": Australia After Nod To Covishield
Australia today said it was looking forward to welcoming Indian students after its top medical regulator approved the Covishield vaccine manufactured by the Serum Institute of India for incoming international travellers.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
-
"Hope To Resolve Soon": Adar Poonawalla On Covishield, EU Travel Issues
Adar Poonawalla tweeted Monday to reassure Covishield-vaccinated Indians facing issues with travel to the European Union - in light of the EU's new 'vaccine passport' scheme not recognising the India-made version of the AstraZeneca vaccine
-
What If Adar Poonawalla Doesn't Want It: High Court Scraps Plea On Security
The Maharashtra government has told the Bombay High Court that it would provide security to Adar Poonawalla, CEO of the Serum Institute of India (SII) which manufacturers the Covishield vaccine against COVID-19, if he makes a request.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Serum Institute Halts Vaccine Production Over Millions Of Unused Doses
Serum Institute of India Ltd., the world's largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making fresh batches of shots after its stockpile grew to 200 million doses amid a global supply
-
Central Drug Regulator Approves Shelf Life Of COVID-19 Vaccines CoviShield, Covaxin, ZyCoV-D
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.
-
Omicron-Specific Booster Shot Possible, Says Adar Poonawalla To NDTV: Highlights
As new Covid strain 'Omicron' raises alarm across the globe, Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, in an exclusive interview to NDTV said that Omicron-specific booster shots are possibl
-
"Vaccine Hesitancy Greatest Threat" In Overcoming Covid: Adar Poonawalla
Adar Poonawalla, the chief of Serum Institute of India which manufactures COVID-19 vaccine Covishield, today said vaccine hesitancy was the "greatest threat" in overcoming the pandemic.
-
"Stress And Anxiety": Adar Poonawalla On Initial Days Of Vaccine Drive
Adar Poonawalla, chief of the Serum Institute of India which manufactures the Covishield vaccine, today admitted to stress and anxiety in the initial days of the vaccination drive. The second wave, he added, was worse.
-
Covid Booster Shot "Early Next Year, But...": Adar Poonawalla to NDTV
Adar Poonawalla, the chief of Serum Institute which is manufacturing Covishield, today said the billionth dose of coronavirus vaccine is a milestone for India and over the next two months, the country will catch up further. There is even a possibili
-
"I Got India's Covishield Vaccine": UN General Assembly President Abdulla Shahid
President of the 76th session of the UN General Assembly Abdulla Shahid has said he had received the two doses of the Covishield vaccine manufactured in India, as have a "large portion" of other countries around the world.
-
"Look Forward To Welcome Indian Students": Australia After Nod To Covishield
Australia today said it was looking forward to welcoming Indian students after its top medical regulator approved the Covishield vaccine manufactured by the Serum Institute of India for incoming international travellers.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
-
"Hope To Resolve Soon": Adar Poonawalla On Covishield, EU Travel Issues
Adar Poonawalla tweeted Monday to reassure Covishield-vaccinated Indians facing issues with travel to the European Union - in light of the EU's new 'vaccine passport' scheme not recognising the India-made version of the AstraZeneca vaccine
-
What If Adar Poonawalla Doesn't Want It: High Court Scraps Plea On Security
The Maharashtra government has told the Bombay High Court that it would provide security to Adar Poonawalla, CEO of the Serum Institute of India (SII) which manufacturers the Covishield vaccine against COVID-19, if he makes a request.
